9572 Stock Overview
Engages in supplying medical equipment in Saudi Arabia. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
Al-Razi Medical Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ر.س54.30 |
52 Week High | ر.س64.30 |
52 Week Low | ر.س41.10 |
Beta | 0 |
11 Month Change | 26.28% |
3 Month Change | 23.97% |
1 Year Change | -6.70% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 49.18% |
Recent News & Updates
Recent updates
Shareholder Returns
9572 | SA Healthcare | SA Market | |
---|---|---|---|
7D | 14.3% | -1.5% | -0.04% |
1Y | -6.7% | -2.4% | -9.2% |
Return vs Industry: 9572 underperformed the SA Healthcare industry which returned -2.4% over the past year.
Return vs Market: 9572 matched the SA Market which returned -9.2% over the past year.
Price Volatility
9572 volatility | |
---|---|
9572 Average Weekly Movement | 9.0% |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 4.1% |
10% most volatile stocks in SA Market | 7.5% |
10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 9572's share price has been volatile over the past 3 months compared to the SA market.
Volatility Over Time: 9572's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of SA stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1986 | 123 | n/a | www.razimed.com |
Al-Razi Medical Company engages in supplying medical equipment in Saudi Arabia. It sells hospital beds, steam and suction devices, inhalation devices, masks, needles, oxygen masks, water bladders, bandages, gloves, and ear rings and piercings. The company serves hospitals, clinics, medical centers, medical companies, and pharmacies.
Al-Razi Medical Company Fundamentals Summary
9572 fundamental statistics | |
---|---|
Market cap | ر.س76.00m |
Earnings (TTM) | ر.س89.78k |
Revenue (TTM) | ر.س61.99m |
919.3x
P/E Ratio1.3x
P/S RatioIs 9572 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9572 income statement (TTM) | |
---|---|
Revenue | ر.س61.99m |
Cost of Revenue | ر.س45.66m |
Gross Profit | ر.س16.34m |
Other Expenses | ر.س16.25m |
Earnings | ر.س89.78k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.059 |
Gross Margin | 26.35% |
Net Profit Margin | 0.14% |
Debt/Equity Ratio | 10.1% |
How did 9572 perform over the long term?
See historical performance and comparison